Unknown

Dataset Information

0

Micheliolide suppresses LPS-induced neuroinflammatory responses.


ABSTRACT: Microglia-involved neuroinflammation is thought to promote brain damage in various neurodegenerative disorders. Thus, inhibition of microglial over-activation may have a therapeutic benefit for the treatment of neurodegenerative disorders. Micheliolide (MCL) is a sesquiterpene lactone which inhibits various inflammatory response. However, whether MCL can inhibit neuroinflammation caused by LPS-activated BV2 microglia has not yet been explored. In this study, we demonstrated that treatment of BV2 cells with MCL significantly repressed LPS-stimulated nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression, as well as tumor necrosis factor-alpha (TNF-?), interleukin-6 (IL-6) and nitric oxide (NO) induction. MCL also attenuated mRNA levels of multiple pro-inflammatory cytokines and mediators such as iNOS, COX-2, TNF-?, IL-6 and IL-1?. Mechanistic studies revealed that MCL suppressed LPS-stimulated the activation of I?B?/NF-?B pathway and Akt pathway. Moreover, MCL inhibited LPS-induced the activition of c-Jun N-terminal kinase (JNK), p38 MAPK kinase, and extracellular signal-regulated kinases 1/2 (ERK1/2). Meanwhile, MCL markedly promoted antioxidant protein heme oxygenase-1 (HO-1) expression by enhancing NF-E2-related factor 2 (Nrf2) activity. Together, our results imply that MCL may serve as a neuroprotective agent in neuroinflammation-related neurodegenerative disorders.

SUBMITTER: Sun Z 

PROVIDER: S-EPMC5645131 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Micheliolide suppresses LPS-induced neuroinflammatory responses.

Sun Zhaomeng Z   Li Guodong G   Tong Tanjun T   Chen Jun J  

PloS one 20171017 10


Microglia-involved neuroinflammation is thought to promote brain damage in various neurodegenerative disorders. Thus, inhibition of microglial over-activation may have a therapeutic benefit for the treatment of neurodegenerative disorders. Micheliolide (MCL) is a sesquiterpene lactone which inhibits various inflammatory response. However, whether MCL can inhibit neuroinflammation caused by LPS-activated BV2 microglia has not yet been explored. In this study, we demonstrated that treatment of BV2  ...[more]

Similar Datasets

| S-EPMC6145206 | biostudies-literature
| S-EPMC10005213 | biostudies-literature
| S-EPMC4794649 | biostudies-literature
| S-EPMC6815018 | biostudies-literature
| S-EPMC7412499 | biostudies-literature
| S-EPMC8406772 | biostudies-literature
| S-EPMC7717664 | biostudies-literature
| S-EPMC7018815 | biostudies-literature
| S-EPMC8147048 | biostudies-literature
| S-EPMC6172460 | biostudies-literature